Skip to main content
. 2016 Aug 6;7(37):60446–60460. doi: 10.18632/oncotarget.11108

Figure 6. Myricetin reduces inflammatory cytokines in intestinal polyps and serum.

Figure 6

A. Western blots show a decrease of IL-1β, IL-6 and TNF-α in intestinal polyps in myricetin-treated mice. B. and C. Myricetin reduces serum concentrations of IL-6 (B) and PGE2 (C) as determined by ELISA. Bars represent means ± S.D. of six mice, performed in triplicate. *, p < 0.05; **, p < 0.05 vs. vehicle control mice.